TROG Cancer Research
Members Login   CQMS Login

Bladder, Kidney and Prostate trials now recruiting

TROG 16.03 (CORE) - this study aims to show that the addition of SBRT (stereotactic body radiotherapy) to standard of care improves progression free survival for patients with extra-cranial oligiometastatic disease that has spread from their lung, breast and/or prostate cancer

Primary sponsor: Institute of Cancer Research (ICR)
Collaborating groups: TROG


TROG 15.03 (FASTRACKII) - this study aims to evaluate the activity and efficacy of Stereotactic Ablative Body Radiotherapy (SABR) for the treatment of kidney cancers.

Primary sponsor: TROG
Collaborating group:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)


TROG 14.02 (RAIDER) - this international clinical trial plans to use daily imaging to determine the optimal radiation treatment for bladder cancer patients.

Primary sponsor: Institute of Cancer Research (ICR)
Collaborating groups: TROG

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.